Sig’s “sell” call last week on Ophiomancer was premature. This wasn’t his first error in MTG finance nor will it be his last. This week, Sig recalls some of his previous mistakes and extracts valuable lessons from each one.
Ophiomancer
While buyouts generate a ton of noise on MTG Stocks’ Interests page, the All-time High list often contains more noteworthy movers in the market. This week Sig takes a look at the list and explains why he would still buy some cards on it while others he advocates selling.
Brian DeMars introduces his brainchild Magic variant, the Danger Room. He shares his current list and the philosophy behind it, before looking at Origins for new additions.
Jason Alt relates his rare foray into the world of actual Magic matches before delving into the results from Grand Prix DC.